Monday, March 16, 2015

Top Healthcare Technology Companies To Buy Right Now

Judging from the big rise in the stock market this morning, you might reasonably think that Federal Reserve Chairman Ben Bernanke had come out with an illuminating speech explaining exactly what the Fed plans to do in every possible contingency going forward. Yet investors got no such promises from the Fed, instead taking it on faith that the central bank will continue its successful management of monetary policy when it meets later this week. Even that was enough to send markets soaring, with the Dow Jones Industrials (DJINDICES: ^DJI  ) climbing 165 points by 10:45 a.m. EDT in a broad-based rally that sent stocks higher around the world.

Yet investors need to understand that there's only so much the Fed can do to eliminate uncertainty about its future actions. The key to the Fed's ability to manage the economy is its ability to surprise the financial markets when necessary, and the Fed therefore won't show all its cards for fear that doing so would reduce its effectiveness going forward. Moreover, with Bernanke himself seen leaving his role as Fed chairman at the beginning of next year, investors will have a new Fed leader to get familiar with at what will be a pivotal time for interest rate policy and the economy.

5 Best Value Stocks To Invest In Right Now: Anika Therapeutics Inc.(ANIK)

Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company offers orthobiologics products for providing relief from the pain of osteoarthritis, and regenerating damaged tissue, such as cartilage defects; ORTHOVISC for the treatment of osteoarthritis of the knee and various joints; ORTHOVISC mini for the treatment of osteoarthritis in small joints; and MONOVISC, a single injection product used for the treatment of osteoarthritis in various joints. It also provides wound care products that comprise Hyalograft 3D for the regeneration of skin; and Hyalomatrix for the treatment of burns and ulcers. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, and AnikaVisc which are injectable HA products used as viscoelastic agents in o phthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides INCERT, a HA based product for the prevention of post-surgical adhesions; Hyalobarrier and Hyalobarrier Endo, which are post operative adhesion barriers for abdominal indications; and HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. Additionally, the company offers Merogel, a product used for the treatment of ear, nose, and throat disorders; and provides dermal fillers for facial wrinkles and scar remediation under the ELEVESS and HYDRELLE brand names. It markets its products directly, as well as through a network of distributors primarily in the United States and Europe. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

Advisors' Opinion:
  • [By STOCKPICKR]

     

    Anika Therapeutics (ANIK), together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair in the U.S., Europe, and internationally. This stock closed up 2.1% to $48.86 in Monday's trading session.

     

    Monday's Volume: 1.25 million

    Three-Month Average Volume: 347,160

    Volume % Change: 272%

     

    From a technical perspective, ANIK jumped higher here right above some near-term support at $46 with above-average volume. This spike higher on Monday briefly pushed shares of ANIK into breakout territory, since the stock flirted with some near-term overhead resistance levels at $49.21 to $49.37. Shares of ANIK tagged an intraday high of $51.40, before it closed below that level at $48.86. Market players should now look for a continuation move to the upside in the short-term if ANIK manages to take out Monday's high of $51.36 to its 52-week high of $52.49 with high volume.

     

    Traders should now look for long-biased trades in ANIK as long as it's trending above Monday's low of $47.57 or above $46 and then once it sustains a move or close above $51.36 to $52.49 with volume that hits near or above 347,160 shares. If that move begins soon, then ANIK will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $55 to $60.

     

Top Healthcare Technology Companies To Buy Right Now: Mostostroy No6 OAO (MSTF)

Mostostroy No6 OAO (Mostostroitel��yi trest No 6 OAO or Bridge Construction Trust N 6 OJSC) is a Russia-based company engaged in the construction industry. Its services portfolio includes the design, construction, reconstruction and renovation of bridges, railways, highways, tunnels and subways, nuclear and thermal power stations, residential and industrial facilities, among others. Mostostroitel��yi trest No 6 OAO provides its services mainly to companies engaged in the transportation, hydraulic engineering, industrial, civil and nuclear construction sectors and its customers include ROSATOM and Russian Railways, among others. The Company operates through 10 branches, as well as two representative offices, located in Moscow and Sochi. In addition, it has five wholly owned subsidiaries. As of March 4, 2011, the Company�� major shareholder was Malakhit OOO with a stake of 19.85%. Advisors' Opinion:
  • [By Tom Taulli]

    But again, the most glaring red flag is the valuation of GOOG stock. Shares of Google stock are currently trading at a P/E ratio of 30, which is certainly rich. Consider that�Apple (AAPL) and �Microsoft (MSTF) sport multiples of only about 14. These companies also have decent dividend yields.

Top Healthcare Technology Companies To Buy Right Now: IDEXX Laboratories Inc (IDXX)

IDEXX Laboratories, Inc., incorporated in 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. In August 2013, IDEXX Laboratories, Inc. announced that it has acquired Madasa do Brasil Ltda.

The Company sells a range of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its primary products and services are point-of-care veterinary diagnostic products, consisting of instruments and consumables and rapid assays; veterinary reference laboratory diagnostic and consulting services used by veterinarians; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; practice management systems and services and digital radiography systems used by veterinarians; products that test milk for antibiotic residues and other contaminants, and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market.

Companion Animal Group

The Company markets a range of in-clinic laboratory analyzers for use in providing reference laboratory quality diagnostic results in companion animal veterinary practices, which it refers ! to as the IDEXX VetLab suite of analyzers. The Company sells two chemistry analyzers, the Catalyst Dx Chemistry Analyzer and the VetTest Chemistry Analyzer, that are used by veterinarians to measure levels of certain enzymes and other substances in blood or urine for monitoring health status and assistance in diagnosing physiologic conditions. Both instruments use consumables manufactured for IDEXX by Ortho-Clinical Diagnostics, Inc. (Ortho), a subsidiary of Johnson & Johnson, based on Ortho�� dry slide technology (Catalyst Dx slides, VetTest slides or slides). In addition, the Catalyst Dx analyzer also uses dry slide electrolyte consumables manufactured by IDEXX at OPTI Medical Systems, one of its wholly owned subsidiaries. Blood tests commonly run on these analyzers include glucose, alkaline phosphatase, alanine aminotransferase (ALT), albumin, creatinine, blood urea nitrogen (BUN), and total protein. Tests are sold individually and in prepackaged panels. Both analyzers also run a urine test called urine protein:creatinine ratio, which assists in the detection of early renal disease.

The Catalyst Dx analyzer is the Company�� chemistry analyzer. The Catalyst Dx analyzer allows a veterinarian to run multiple patient samples simultaneously; to run different sample types, including whole blood, plasma, serum and urine; to perform 28 different chemistry and electrolyte tests; and to automatically calculate other parameters and ratios important to blood chemistry analysis. Its VetLyte Electrolyte Analyzer measures three electrolytes-sodium, potassium and chloride-to aid in evaluating acid-base and electrolyte balances and assessing plasma hydration. Its VetStat Electrolyte and Blood Gas Analyzer measures electrolytes, blood gases, glucose and ionized calcium, and calculates other parameters, such as base excess and anion gap. These measurements aid veterinarians in diagnosing various disease states, evaluating fluid therapy choices and measuring respiratory function. The VetStat analyzer ru! ns single! -use disposable cassettes that contain various configurations of analytes. The VetStat analyzer and its cassettes are manufactured by OPTI Medical Systems.

The Company sells three hematology analyzers that assess the cellular components of blood, including red blood cells, white blood cells and platelets (also called a complete blood count (CBC)). These analyzers include the ProCyte Dx Hematology Analyzer, which uses laser-flow cytometry, optical fluorescence and laminar-flow impedance in its analysis; the LaserCyte Hematology Analyzer, which uses laser-flow cytometry technology in its analysis, and the IDEXX VetAutoread Hematology Analyzer. It also sells the Coag Dx Analyzer, which permits the detection and diagnosis of blood clotting disorders. The ProCyte Dx analyzer provides validated results for five species (canine, feline, equine, bovine and ferret) for up to 24 different blood parameters, providing a more complete picture of each patient�� health.

The SNAPshot Dx analyzer provides quantitative measurements of total thyroxine (T4), cortisol and bile acids to assist in the evaluation of thyroid, adrenal and liver function. The SNAPshot Dx analyzer also reads, interprets and records the results of many IDEXX rapid assay SNAP tests, including its canine SNAP 4Dx test, feline SNAP FIV/FeLV Combo test, canine SNAP cPL test, feline SNAP fPL test, SNAP Feline Triple test and canine SNAP Heartworm RT test. The IDEXX VetLab UA Analyzer provides chemical urinalysis and is validated specifically for veterinary use. The IDEXX VetLab Station (IVLS) connects and integrates the diagnostic information from all the IDEXX VetLab equipment and thus provides reference laboratory information management system capability. It sells the IVLS as an integral component of the Catalyst Dx, LaserCyte and ProCyte Dx analyzers and also as a standalone hardware platform.

The IVLS includes a user interface to input patient information, connect with a practice management system and send i! nformatio! n to run the individual analyzers. IVLS also generates one integrated patient report incorporating all of the lab work generated by the IDEXX VetLab suite; stores, retrieves and analyzes historical patient diagnostics data, including SNAP test results; and sends and receives information from practice management systems, including the IDEXX Cornerstone system, as well as a variety of third-party systems. It sells a range of single-use, handheld test kits under the SNAP name. In addition to its single-use tests, it sells a range of microwell-based test kits under the PetChek name for canine heartworm, FIV and FeLV.

The Company offers commercial reference laboratory diagnostic and consulting services to veterinarians in the United States, Canada, Europe, Australia, Japan, South Africa, China and South Korea and to bioresearch customers in the United States and Europe. The Company provides specialized veterinary consultation, telemedicine and advisory services, including radiology, cardiology, internal medicine and ultrasound consulting. It develops, markets and sells practice management systems, including hardware and software, and services that run certain functions of veterinary clinics, including managing patient electronic health records, scheduling (including boarding and grooming), reminders, billing and inventory management.

The Company markets and sells two digital radiography systems for use in the small animal veterinary hospital: the IDEXX-DR 1417 and the IDEXX I-Vision CR. Its digital radiography systems use IDEXX-PACS and IDEXX EquiView PACS picture archiving and communication system (PACS) software for the viewing, manipulation, management, storage and retrieval of the digital images generated by the digital capture plate. In September 2011, the Company launched IDEXX I-Vision Mobile, an application that allows veterinarians with the IDEXX-DR 1417 and IDEXX I-Vision CR systems, as well as its digital radiography systems, to request, view and send images using an iPa! d or an A! ndroid mobile tablet. This application integrates with its IDEXX-PACS software.

Water

The Company offers a range of products used in the detection and quantification of various microbiological parameters in water. Its principal products are the Colilert, Colilert-18 and Colisure tests, which simultaneously detect the presence of total coliforms and E. coli in water. These organisms are used as indicators of microbial contamination in water. These products utilize indicator-nutrients that produce a change in color or fluorescence when metabolized by target microbes in the sample. Its water tests are used by government laboratories, water utilities and private certified laboratories to test drinking water. The tests also are used in evaluating water used in production processes (for example, in beverage and pharmaceutical applications) and in evaluating bottled water, recreational water, waste water and water from private wells.

Livestock and Poultry Diagnostics

The Company sells diagnostic tests and related instrumentation that are used to detect a range of diseases and to monitor health status in livestock and poultry. Its livestock and poultry diagnostic products are purchased by government and private laboratories that provide testing services to cattle, swine and poultry veterinarians and producers. Its principal products include tests for Bovine Viral Diarrhea Virus (BVDV), Porcine Reproductive and Respiratory Syndrome (PRRS) and Bovine Spongiform Encephalopathy (BSE or mad cow disease). BVDV is a common and contagious viral infection that suppresses the immune system, making the animal susceptible to a host of other infections, impacting beef and dairy production yields as a result. PRRS is a contagious virus causing reproductive problems and respiratory diseases. BSE is a fatal neurodegenerative disease in cattle that causes a spongy degeneration in the brain and spinal cord.

Other

The principal products in the Company�! � Dairy ! business are its SNAP tests used to detect antibiotic drug-residue in milk. Its primary product line for detecting antibiotic residue in milk is SNAP Beta-Lactam, which detects penicillin, amoxicillin, ceftiofur and cephaphirin residues, followed by SNAPduo Beta-Tetra, which detects certain tetracycline antibiotic residues in addition to those detected by the SNAP Beta Lactam test kits. It also sells SNAP tests for the detection of certain other contaminants in milk, such as chemical melamine and Alfatoxin M1.

The Company sells OPTI point-of-care analyzers and related consumables for use in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, BUN and ionized calcium, and to calculate other parameters, such as base excess and anion gap. These analyzers are used primarily in emergency rooms, operating rooms, cardiac monitoring areas and other locations where time-critical diagnostic testing is performed within the hospital setting. The OPTI CCA and OPTI Touch Electrolyte and Blood Gas Analyzers run single-use disposable cassettes that contain various configurations of analytes; the OPTI R Analyzer runs reusable cassettes in various analyte configurations; and the OPTI LION Stat Electrolyte Analyzer runs single-use electrolyte cassettes. OPTI Medical Systems also manufactures its VetStat analyzer and provides the electrolyte module and dry slide reagents that make up the electrolyte testing functionality of the Catalyst Dx analyzer.

The Company competes with VCA Antech, Inc., Abaxis, Inc., Butler, Radiometer A/S, Siemens Medical Solutions Diagnostics, Instrumentation Laboratory, Abbott Diagnostics and Roche Diagnostics.

Advisors' Opinion:
  • [By Sean Williams]

    Ignore this trend at your own risk
    If you choose to do nothing, then you're playing right into the hands of pharmaceutical giants like Zoetis (NYSE: ZTS  ) , Merck (NYSE: MRK  ) , and IDEXX Laboratories (NASDAQ: IDXX  ) , which are counting on your indifference to drive their profits.

  • [By CanadianValue]

    Idexx (IDXX) performed well in 2011, generating solid revenue growth and high-teens earnings growth thanks to a slight recovery in the veterinary end market, the ramp up of its new ProCyte hematology instrument, continued share gains in reference laboratories and one-time gains from production animal disease eradication programs in Europe. While we continue to like the company�� prospects and are impressed with its execution in a still sluggish market for animal healthcare, we trimmed our position in 2011 at prices we found attractive given our expectations for the business.

  • [By Sean Williams]

    On the diagnostic side, there isn't a company better equipped to help veterinarians diagnose bone and organ disease, or help veterinarians improve the efficiency of their software, than IDEXX Laboratories (NASDAQ: IDXX  ) . From small diagnostic analyzers to high-tech digital imagery and even consultation calls, IDEXX does it all for owners and veterinarians. The best part is that the company's companion diagnostics make up the bulk (83%) of its revenue, so the chance of IDEXX seeing a slowdown in demand appears pretty minimal.

  • [By Tim Brugger]

    After 10 years on the board of IDEXX Laboratories (NASDAQ: IDXX  ) , including serving on its audit and compensation committees, Brian McKeon has been named IDEXX's new executive vice president and CFO, the company announced today. McKeon's appointment as CFO becomes effective Jan. 1, though he has resigned from the IDEXX board as of Oct. 11, the company said.

Top Healthcare Technology Companies To Buy Right Now: Axis Capital Holdings Limited (AXS)

AXIS Capital Holdings Limited provides specialty lines insurance and treaty reinsurance products in Bermuda, the United States, Europe, Singapore, Canada, Australia, and Latin America. The company�s Insurance segment offers property insurance for commercial buildings, residential premises, construction projects, and onshore energy installations; marine insurance covering offshore energy, cargo, liability, recreational marine, fine art, specie, hull, and war; and aviation, terrorism, credit and political risk, and liability insurance. It also provides professional lines that cover directors� and officers� liability, errors and omissions liability, employment practices liability, fiduciary liability, crime, professional indemnity, and other financial insurance related coverage; and accidental death, travel, and specialty health products for employer and affinity groups, financial institutions, schools, and colleges, as well as accident and health reinsurance for catastrop hic or per life events. This segment offers its products through wholesale and retail brokers, managing general agents, and underwriters. Its Reinsurance segment provides non-life reinsurance to insurance companies, including catastrophe; property reinsurance covering property damage and related losses resulting from natural and man-made perils; professional lines; credit and bond reinsurance; and motor reinsurance providing coverage to cedants for motor liability and property damage losses. This segment also offers coverage to insurers of standard casualty business, excess and surplus casualty business, and specialty casualty programs; coverage for various types of construction risks and risks associated with the erection, testing, and commissioning of machinery and plants during the construction stage; and aviation, marine, personal accident, and crop reinsurance. AXIS Capital Holdings Limited was founded in 2001 and is headquartered in Pembroke, Bermuda.

Advisors' Opinion:
  • [By Dividends4Life]

    Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CINF is trading at a discount to only 3.) above. The stock is trading at a 36.8% premium to its calculated fair value of $34.96. CINF did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CINF earned two Stars in this section for 1.) and 2.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. The company has paid a cash dividend to shareholders every year since 1954 and has increased its dividend payments for 54 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $62 is below the $500 target I look for in a stock that has increased dividends as long as CINF has. If CINF grows its dividend at 1.2% per year, it will take 5 years to equal a MMA yielding an estimated 20-year average rate of 3.68%. Memberships and Peers: CINF is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Divid

Top Healthcare Technology Companies To Buy Right Now: EnerNOC Inc (ENOC)

EnerNOC, Inc. (EnerNOC), incorporated on June 5, 2003, is a provider of energy management applications, services and products for the smart grid, which include demand response, data-driven energy efficiency, and energy price and risk management applications, services and products. The Company�� energy management applications, services and products enable energy management strategies for commercial, institutional and industrial end-users of energy, which it refers to as its C&I customers, and its electric power grid operator and utility customers by reducing real-time demand for electricity, increasing energy efficiency and improving energy supply transparency. The Company�� energy management applications, services and products include its EnerNOC EfficiencySMART and SupplySMART applications and services, and certain wireless energy management products.

DemandSMART

The Company�� demand response capacity provides an alternative to building conventional supply-side resources, such as natural gas-fired peaking power plants, to meet periods of peak electricity demand. The Company is in the development, implementation and broader adoption of technology-enabled demand response services for the smart grid. The Company�� DemandSMART application enables us to send control signals to, and receive bi-directional communications from, an Internet-enabled network of dispersed C&I customer sites in order to initiate, monitor and complete demand response activity. The Company�� technology and operational processes have the ability to automate demand response and simplify C&I customer participation by remotely reducing electricity usage in a matter of minutes, or send curtailment instructions to its C&I customers to be manually implemented on site. The devices that it installs at its C&I customer sites transmit to us through the cellular network and Internet near real-time electrical consumption data on a 1-minute, 5-minute, 15-minute or hourly basis. The Company�� DemandSMART app! lication analyzes the data from individual sites and aggregates data for specific regions. When a demand response event occurs, its network operations center (NOC) automatically processes the notification coming from the electric power grid operator or utility. The Company�� NOC operators then begin activating procedures to curtail demand from the grid at its C&I customer sites.

The Company provides its demand response services to electric power grid operators and utilities under long-term contracts and pursuant to open market bidding programs. The Company�� long-term contracts generally have terms of 3-10 years and predetermined capacity commitment and payment levels. Within these contracts and open market programs, it offers the services to address the needs of electric power grid operators and utilities: reliability-based demand response, price-based demand response, and short-term reserve resources referred to in the electric power industry as ancillary services.

EfficiencySMART

EfficiencySMART is the Company�� data-driven energy efficiency suite that includes energy efficiency planning, audits, assessments, commissioning and retro-commissioning authority services, and a cloud-based energy analytics application used for managing energy across a C&I customer�� portfolio of sites. The cloud-based energy analytics application also includes the ability to integrate with a C&I customer�� existing energy management system, provide utility bill management and tools for measurement, tracking, analysis, reporting and management of greenhouse gas emissions. The Company offers the EfficiencySMART applications and services, which include EfficiencySMART Plan, EfficiencySMART Audit, EfficiencySMART Assessment, EfficiencySMART Commissioning and EfficiencySMART Insight.

EfficiencySMART Plan provides its C&I customers with a multi-year profile of projected energy demand, consumption and costs, including a lifecycle financial analysis of potential energy! strategi! es and a roadmap for implementation. EfficiencySMART Audit provides its C&I customers with energy efficiency recommendations in compliance with the American Society of Heating, Refrigeration and Air-Conditioning (ASHRAE) standards for conditioned space, and tactical energy surveys for industrial facilities. EfficiencySMART Assessment provides detailed recommendations for energy savings, demand reductions, reductions in energy intensity through operation and maintenance activities, equipment retrofits, behavioral changes, or the use of new technologies. EfficiencySMART Commissioning includes traditional and/or new building commissioning services, such as investigation, testing and verification of energy efficiency strategies, and data analytics over a specified period of time. EfficiencySMART Insight provides its large, multi-site C&I customers with a Software-as-a-Service enterprise energy management solution that provides persistent commissioning with the ability to visualize near real-time energy usage, identify savings opportunities, and prioritize energy-related investments across a portfolio of meters and buildings across a C&I customer�� organization.

SupplySMART

SupplySMART is the Company�� energy price and risk management application that provides its C&I customers located in restructured or deregulated markets throughout the United States with the ability to more effectively manage the energy supplier selection process, including energy supply product procurement and implementation. SupplySMART provides a framework for developing and implementing risk management strategies and executing purchasing strategies that provides maximum price transparency and structural savings on an ongoing basis for its C&I customers.

Technology and Operations

The Company�� technology has been developed provides a platform on which to design, customize, and implement its energy management applications, services and products. The Company�� technology infrast! ructure i! s built on Linux, Java and Oracle, and supports open Web services architecture. The Company�� enterprise energy management application platform enables the Company to efficiently scale its DemandSMART, EfficiencySMART, and SupplySMART applications and services, as well as certain wireless energy management products, in new geographic regions and rapidly grow the number of C&I customers in its network. The Company�� energy management application platform leverages Web services and wireless technologies that connect applications directly with other applications through a form of loose coupling, which allows connections to be established across applications without customization.

Network Operations Center

The Company�� technology enables its NOC to automatically respond to signals sent by electric power grid operators and utilities to deliver demand reductions within targeted geographic regions. The Company can customize its technology to receive and interpret many types of dispatch signals sent directly from an electric power grid operator or utility customer to its NOC. Following the receipt of such a signal, its NOC automatically notifies specified C&I customer personnel of the demand response event. After relaying this notification to its C&I customers, it initiate processes that reduce their electricity consumption from the electric power grid. These processes may include dimming lights, shifting equipment to power save mode, adjusting heating and cooling set points and activating a back-up generator. Demand reduction is monitored remotely with near real-time data feeds, the results of which are displayed in its NOC through various data presentment screens.

Energy Management Platform

The Company�� energy management platform is consists of its cloud-based enterprise software platform used for DemandSMART, EfficiencySMART and SupplySMART, as well as wireless energy management products and technology, and is the underlying system that runs its ! NOC. It u! tilizes a modular Web services architecture that is designed to allow application modules to be easily integrated into the platform. The Company use its energy management platform to measure, manage, benchmark and optimize C&I customers��energy consumption and facility operations. The Company use this data to help C&I customers analyze consumption patterns, forecast demand, measure real-time performance during demand response events, continuously monitor building management equipment to optimize system operation, model rates and tariffs and create energy scorecards to benchmark similar facilities. In addition, its energy management application platform has the ability to track its C&I customers��greenhouse gas emissions by mapping their energy consumption with the fuel mix used for generation in their location, such as the proportion of coal, nuclear, natural gas, fuel oil and other sources used.

The EnerNOC Site Server

The Company designs and installs a small device, called an EnerNOC Site Server, or ESS, at each C&I customer site to collect and communicate to its platform near real-time electricity consumption data and, in certain cases, enable remote control of a C&I customer�� electricity consumption. The ESS communicates to its NOC through the C&I customer�� LAN or secure Internet connection. The ESS is an open, integrated system consisting of a central hardware device residing inside a standard electrical box. The ESS allows its C&I customers to, among other things, respond quickly and completely to instructions from us to reduce electricity consumption. The Company also supports OpenADR protocol on its most recent ESS devices, an emerging standard for automated demand response communications.

The Company competes with Comverge, Inc., Exelon Corporation, Energy Curtailment Specialists and Hess, Inc., as well as energy technology providers Lucid Design Group, Inc., Building IQ, SCIEnergy, Inc. and McKinstry Co., LLC.

Advisors' Opinion:
  • [By Alyce Lomax]

    Apparently EnerNOC's (NASDAQ: ENOC  ) first-quarter results didn't do much for investors. The stock sagged after it reported its financial results several days ago. Still, trader-centric investors are likely missing a lot about this disruptive company's story and long-term prognosis.�

  • [By Alyce Lomax]

    After surging in recent months, EnerNOC (NASDAQ: ENOC  ) shares have sputtered out again. Developments concerning a major customer underline the evolving landscape for a company like this one. Right now, investors aren't exhibiting much demand for this demand response company.

  • [By Chris Hill]

    Shares of EnerNoc (NASDAQ: ENOC  ) and Exelon (NYSE: EXC  ) lose energy in the wake of analyst downgrades. Netflix (NASDAQ: NFLX  ) falls after releasing the fourth season of Arrested Development. And Beazer Homes (NYSE: BZH  ) benefits from rising home prices. In this installment of Investor Beat, our analysts discuss four stocks making moves.

Top Healthcare Technology Companies To Buy Right Now: American Science and Engineering Inc.(ASEI)

American Science and Engineering, Inc., together with its subsidiaries, develops, manufactures, markets, and sells X-ray inspection and other detection products for detection and security screening solutions in the United States and internationally. It offers cargo inspection systems comprising non-intrusive inspection products, which are primarily used for the screening of trucks, cars, cargo containers, pallets, and air cargo at border crossings, seaports, military bases, airports, and cargo and transportation hubs. The cargo inspection systems include OmniView gantry system, a cargo and vehicle inspection system; Z Portal system, a drive-through inspection system for scanning cargo and vehicles; Z Gantry system, a Z Backscatter inspection system for scanning cars, vans, trucks, and their cargo; Sentry Portal system, a drive through transmission X-ray inspection system; and MobileSearch High-Energy, a mobile inspection system for scanning trucks, cargo containers, and ve hicles. The company also provides Z Backscatter systems, including Z Backscatter Van, a mobile X-ray screening system to produce photo-like images of plastic explosives or other anomalies; and ZBV Military Trailer, a rugged X-ray screening system built on military trailer. In addition, it offers parcel and personnel screening inspection system that comprises Gemini system, a parcel and baggage inspection system; and SmartCheck system, a personnel screening system for screening threats hidden under a person?s clothing. Further, the company provides contract research and development programs for agencies of the United States government; and maintenance, warranty, engineering, and training services. It serves authorities responsible for port and border security, customs agencies, military organizations, high threat commercial and government facilities, aviation security agencies, and law enforcement agencies. The company was founded in 1958 and is headquartered in Billerica, M assachusetts.

Advisors' Opinion:
  • [By Bryan Murphy]

    It's tragic that it takes an event like the one earlier this week at a Nevada middle school to put building security stocks in the spotlight. But, reality is reality. The death of one teacher as well as the student/shooter himself has once again underscored the need for names like View Systems Inc. (OTCBB:VSYM), OSI Systems, Inc. (NASDAQ:OSIS), and American Science & Engineering, Inc. (NASDAQ:ASEI). These three companies make equipment that may have prevented the shooting at the school. As is so often the case, interest in defense-oriented equipment - and a stronger likelihood of buying them - is eventually going to impact stocks like ASEI, OSIS, and VSYM for the better.

  • [By Rich Smith]

    An unidentified "government agency" has awarded American Science & Engineering (NASDAQ: ASEI  ) a $60 million contract to supply X-ray inspection systems, the company (partially) revealed Tuesday.

No comments:

Post a Comment